Loop Capital Maintains Tempus AI(TEM.US) With Buy Rating, Raises Target Price to $57
Tempus AI Analyst Ratings
BofA Securities Downgrades Tempus AI(TEM.US) to Hold Rating, Raises Target Price to $60
Tempus AI Downgraded to Neutral at BofA on Valuation
Tempus AI Downgraded to Neutral From Buy at BofA
Buy Rating Affirmed for Personalis Amidst Rapid Commercialization and Strong Tempus AI Partnership
Tempus AI Analyst Ratings
Analysts Conflicted on These NA Names: Astera Labs, Inc. (ALAB) and Tempus AI, Inc. Class A (TEM)
Tempus AI Price Target Maintained With a $47.00/Share by Needham
Tempus AI Analyst Ratings
TD Cowen Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $50
Buy Rating Justified for Tempus AI, Inc. Class A on Strong Q1 Performance and Upbeat 2024 Guidance
Stifel Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $45
Stifel Nicolaus Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)
TD Cowen Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $50
Maintained Buy Rating for Tempus AI, Inc. Class A Amid Inconsequential Financial Adjustments
Needham Initiates Tempus AI at Buy With $47 Price Target
Buy Rating Affirmed for Tempus AI, Inc. on Strong Growth and AI-Driven Healthcare Innovation
Tempus AI Analyst Ratings